BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 75734)

  • 1. The diagnostic problem in multiple sclerosis (M.S.): two specific laboratory tests.
    Field EJ
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):552-6. PubMed ID: 75734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The macrophage electrophoretic mobility LAD test--a diagnostic method for multiple sclerosis (author's transl)].
    Meyer-Rienecker H; Jenessen HL; Köhler H; Günther JK
    J Neurol; 1976 Feb; 211(3):229-40. PubMed ID: 55489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visual evoked potentials and the E-UFA test. Laboratory contribution to the diagnosis of multiple sclerosis].
    Ghezzi A; Caputo D; Vanzulli F; Zibetti A
    Minerva Med; 1979 Sep; 70(42):2883-8. PubMed ID: 492555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytopherometry in neurologic diseases (author's transl)].
    Meyer-Rienecker HJ; Jenssen HL; Köhler H; Werner H
    Fortschr Neurol Psychiatr Grenzgeb; 1977 Nov; 45(11):615-29. PubMed ID: 336499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-UFA test in multiple sclerosis.
    Bisaccia G; Caputo D; Zibetti A
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):583-8. PubMed ID: 629850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics.
    Carnegie PR; Caspary EA; Dickinson JP; Field EJ
    Clin Exp Immunol; 1973 May; 14(1):37-45. PubMed ID: 4716103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
    Light PA; Preece AW; Waldron HA
    Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific laboratory test for diagnosis of multiple sclerosis.
    Field EJ; Shenton BK; Joyce G
    Br Med J; 1974 Mar; 1(5905):412-4. PubMed ID: 4856264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specificity of laboratory test for diagnosis of multiple sclerosis.
    Mertin J; Hughes D; Caspary EA; Thomson AM; Foster JB; Stewart-Wynne EG
    Br Med J; 1974 Dec; 4(5944):567-9. PubMed ID: 4434141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
    Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
    Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The linoleic acid depression (LAD) test for multiple sclerosis using the macrophage electrophoretic mobility (MEM) test.
    Jenssen HL; Meyer-Rienecker HJ; Köhler H; Günther JK
    Acta Neurol Scand; 1976 Jan; 53(1):51-60. PubMed ID: 1251680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophoretic mobility test for lymphocyte sensitization using tanned sheep erythrocytes.
    Jenssen HL; Shenton BK
    Acta Biol Med Ger; 1975; 34(4):K 29-32. PubMed ID: 1237979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte electrophoretic mobility test for multiple sclerosis.
    Caputo D; Ghezzi A; Zibetti A; Di Costanzo M
    Boll Ist Sieroter Milan; 1980 Mar; 59(1):70-1. PubMed ID: 7459016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of the macrophage electrophoretic mobility test (M.E.M.).
    Shenton BR
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical aspects of lipid metabolism in multiple sclerosis].
    Caputo D; Bisaccia G; Manara F; Zibetti A; Ghezzi A
    Arch Sci Med (Torino); 1978; 135(4):473-6. PubMed ID: 389199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukocyte migration inhibition test in multiple sclerosis - results of a migration technic according to Clausen using brain specific antigens].
    Lehmitz R; Meyer-Rienecker HJ; Werner H; Eichler R
    Psychiatr Neurol Med Psychol (Leipz); 1980 Oct; 32(10):577-87. PubMed ID: 6164068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of multiple sclerosis. Antibody dependent cytotoxicity of lymphocytes against myelin basic proteins in multiple sclerosis].
    Frick E; Stickl H
    Fortschr Med; 1977 Oct; 95(37):2235-41. PubMed ID: 914178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the erythrocyte-UFA (E-UFA) mobility test for the diagnosis of multiple sclerosis.
    Cuypers J; Reddemann H
    J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):995-8. PubMed ID: 7441283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.